The emergence of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide and tirzepatide, has revolutionized the clinical approach to obesity and…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.